AAAAAA
Results:
1-7
|
Results: 7
Authors:
Mirghani, RA
Ericsson, O
Cook, J
Yu, P
Gustafsson, LL
Citation: Ra. Mirghani et al., Simultaneous determination of quinine and four metabolites in plasma and urine by high-performance liquid chromatography, J CHROMAT B, 754(1), 2001, pp. 57-64
Authors:
Nsimba, SED
Aden-Abdi, Y
Rimoy, G
Massele, AY
Alm, C
Ericsson, O
Gustafsson, LL
Citation: Sed. Nsimba et al., Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand, J CLIN PH T, 26(1), 2001, pp. 43-48
Authors:
Herrlin, K
Massele, AY
Rimoy, G
Alm, C
Rais, M
Ericsson, O
Bertilsson, L
Gustafsson, LL
Citation: K. Herrlin et al., Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype, CLIN PHARM, 68(2), 2000, pp. 189-198
Authors:
Keiser, J
Ericsson, O
Burri, C
Citation: J. Keiser et al., Investigations of the metabolites of the trypanocidal drug melarsoprol, CLIN PHARM, 67(5), 2000, pp. 478-488
Authors:
Warsame, M
Kilimali, VAEB
Wernsdorfer, WH
Lebbad, M
Rutta, AS
Ericsson, O
Citation: M. Warsame et al., Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania, T RS TROP M, 93(3), 1999, pp. 312-313
Authors:
Mirghani, RA
Hellgren, U
Westerberg, PA
Ericsson, O
Bertilsson, L
Gustafsson, LL
Citation: Ra. Mirghani et al., The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quininein vivo, CLIN PHARM, 66(5), 1999, pp. 454-460
Authors:
Bronner, U
Brun, R
Doua, F
Ericsson, O
Burri, C
Keiser, J
Miezan, TW
Boa, YF
Rombo, L
Gustafsson, LL
Citation: U. Bronner et al., Discrepancy in plasma melarsoprol concentrations between HPLC and bioassaymethods in patients with T gambiense sleeping sickness indicates that melarsoprol is metabolized, TR MED I H, 3(11), 1998, pp. 913-917
Risultati:
1-7
|